Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000312069-25-000544·BARCLAYS PLC
Schedule 13G ownership disclosure
Ironwood Pharmaceuticals Inc
COMMON-STOCK · CUSIP: 46333X108
Event date: 2025-06-30
- Filing-level shares
- 11,133,857
- Percent of class
- 6.88%
- Barclays PLC
Shares: 11,133,857 · Class: 6.88%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000312069-25-000544
- Form type
- SCHEDULE 13G
- Filer
- BARCLAYS PLC
- CIK
- CIK 312069
- Filed
- Aug 12, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership